Jung SH - Search Results

1

Importance of sulfonylimidazolidinone motif of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicity: synthesis of 2-benzoyl-4-phenyl[1,2,5]thiazolidine-1,1-dioxides and their cytotoxcity.

Kim IW, Lee CK, Kim HS, Jung SH. Kim IW, et al. Among authors: jung sh. Arch Pharm Res. 2003 Jan;26(1):9-14. doi: 10.1007/BF03179923. Arch Pharm Res. 2003. PMID: 12568350

2

Recognition of the importance of imidazolidinone motif for cytotoxicity of 4-phenyl-1-arylsulfonylimidazolidinones using thiadiazolidine-1,1-dioxide analogs.

Kim IW, Jung SH. Kim IW, et al. Among authors: jung sh. Arch Pharm Res. 2002 Aug;25(4):421-7. doi: 10.1007/BF02976594. Arch Pharm Res. 2002. PMID: 12214848

3

Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response.

Kim BH, Chung EY, Ryu JC, Jung SH, Min KR, Kim Y. Kim BH, et al. Among authors: jung sh. Arch Pharm Res. 2003 Apr;26(4):306-11. doi: 10.1007/BF02976960. Arch Pharm Res. 2003. PMID: 12735689

4

Synthesis and cytotoxic activity of 1-(1-benzoylindoline-5-sulfonyl)-4-phenylimidazolidinones.

Jung SH, Lee HS, Kim NS, Kim HM, Lee M, Choi DR, Lee JA, Chung YH, Moon EY, Hwang HS, Seong SK, Lee DK. Jung SH, et al. Arch Pharm Res. 2004 May;27(5):478-84. doi: 10.1007/BF02980119. Arch Pharm Res. 2004. PMID: 15202551

5

Evaluation of anticancer activity of 4-vinyl-1-arylsulfonylimidazolidinones.

Kwak SH, Bang SC, Seo HH, Shin HR, Lee KC, Le Hoang TA, Jung SH. Kwak SH, et al. Among authors: jung sh. Arch Pharm Res. 2006 Sep;29(9):721-7. doi: 10.1007/BF02974070. Arch Pharm Res. 2006. PMID: 17024843

6

The role of the hydrophobic group on ring A of chalcones in the inhibition of interleukin-5.

Yang HM, Shin HR, Cho SH, Song GY, Lee IJ, Kim MK, Lee SH, Ryu JC, Kim Y, Jung SH. Yang HM, et al. Among authors: jung sh. Arch Pharm Res. 2006 Nov;29(11):969-76. doi: 10.1007/BF02969280. Arch Pharm Res. 2006. PMID: 17146965

7

The role of alkoxy group on the A ring of isoflavones in the inhibition of interleukin-5.

Yang HM, Shin HR, Bang SC, Lee KC, Hoang le TA, Lee IJ, Kim Y, Jung SH. Yang HM, et al. Among authors: jung sh. Arch Pharm Res. 2007 Aug;30(8):950-4. doi: 10.1007/BF02993962. Arch Pharm Res. 2007. PMID: 17879747

8

A convenient preparation of a disaccharide motif and its role in the cytotoxicity of the triterpenoid saponin, alpha-hederin.

Bang SC, Seo HH, Shin HR, Lee KC, Hoang le TA, Jung SH. Bang SC, et al. Among authors: jung sh. Arch Pharm Res. 2008 May;31(5):555-61. doi: 10.1007/s12272-001-1192-7. Epub 2008 May 15. Arch Pharm Res. 2008. PMID: 18481008

9

Physicochemical studies of a newly synthesized molecule, 6-methyl-3-phenethyl-3,4-dihydro-1H-quinazoline-2-thione (JSH18) for topical formulations.

Kim S, Jung SH, Cho CW. Kim S, et al. Among authors: jung sh. Arch Pharm Res. 2008 Oct;31(10):1363-8. doi: 10.1007/s12272-001-2118-x. Epub 2008 Oct 29. Arch Pharm Res. 2008. PMID: 18958429

10

Structure--activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity.

Subramanian S, Kim NS, Thanigaimalai P, Sharma VK, Lee KC, Kang JS, Kim HM, Jung SH. Subramanian S, et al. Among authors: jung sh. Eur J Med Chem. 2011 Aug;46(8):3258-64. doi: 10.1016/j.ejmech.2011.04.042. Epub 2011 Apr 28. Eur J Med Chem. 2011. PMID: 21570750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,303 results

Search Page

Filters